GLPwatch
Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes
NCT00154401 · Completed
Last updated 2026-05-28This clinical trial tested the effect of the medication liraglutide on blood sugar control in adults with type 2 diabetes.
Status Completed The study has finished.
Phase Phase 2 Tests whether it works and watches safety in a moderate group.
Type Interventional (clinical trial)
Design Randomized, double-blind treatment study
Participants 177 people
Who can join Ages 18+ · all sexes
Timeline Started 2005-01 · est. completion 2005-10
Where 39 sites · Denmark, France, Netherlands, Slovakia
What this study is testing ClinicalTrials.gov NCT00154401 ↗
Description as written by the study sponsor.
This trial is conducted in Europe. The trial is designed to show the effect of treatment with liraglutide or placebo on blood glucose control after 14 weeks in subjects with type 2 diabetes. Liraglutide or placebo is administered by injection once daily in the evening. The trial is a multi-national trial with treatment concealed to participating subjects, investigators and the sponsor. Treatment allocation is random with equal chance of being assigned to each group.
Treatments tested
- liraglutide Drug
| Main thing measured | HbA1c |
|---|---|
| Sponsor | Novo Nordisk A/S |
| Conditions studied | Diabetes, Diabetes Mellitus, Type 2 |
| GLP-1 drugs | liraglutide |
Full protocol, eligibility, and contacts on ClinicalTrials.gov NCT00154401 ↗